Metabolic Disorders News and Research

RSS

Advances in DNA technology are reshaping preventive healthcare

A new review highlights how advances in DNA technology are reshaping the future of healthcare by shifting the focus from treatment to prevention.

6 Aug 2026

New review highlights FOXA2's role in glucose regulation pathways

A newly published review highlights the pivotal role of FOXA2, a key transcription factor, in coordinating pancreatic development, maintaining islet cell identity, and regulating glucose homeostasis.

6 Aug 2026

New insights highlight Megalin's expanding role in disease management

A comprehensive new analysis is shining a spotlight on Megalin, a powerful and highly versatile receptor that plays a central role in maintaining cellular balance, organ function, and overall human health.

5 Aug 2026

Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative study in the journal npj Precision Oncology.

4 Aug 2026

Researchers suggest a potential therapeutic strategy for muscle loss associated with obesity

Obesity has been linked to skeletal muscle loss and deterioration. While M2 macrophages may play a role in regulating muscle function, the underlying mechanisms remain poorly understood.

4 Aug 2026

Insilico unveils standardized evaluation framework to validate AI-driven drug discovery models

As general-purpose and domain-specific AI models rapidly infiltrate drug discovery, one critical question looms over the pharmaceutical sector: Can these models actually discover drugs, or are they just good at taking tests?

30 Jul 2026

Jet lag may disrupt athletes' gut microbiome and slow recovery

The interplay between jet lag and gut microbiome affects athlete performance. Strategies to manage these disruptions are crucial but not yet fully established.

30 Jul 2026

FDA grants fast track designation to Insilico's AI-designed mesothelioma drug candidate

Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ISM6331, a novel, potential best-in-class pan-TEAD inhibitor driven by Insilico's proprietary AI, has received Fast Track Designation (FTD) from the U.S.

29 Jul 2026

Signals traveling from the gut through the vagus nerve help form memories

When French writer Marcel Proust famously recalled his childhood from the taste of a Madeline cookie, his stomach may have done some of the work.

27 Jul 2026

Beckman Coulter Diagnostics launches fully automated urinalysis system to meet rising testing volumes

Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced the U.S. launch of the DxU 1800 System, a fully automated urinalysis solution that combines a new chemistry analyzer and consumables with proven microscopy technology.

From Beckman Coulter Diagnostics 27 Jul 2026

Endotrophin may reveal metabolic risks linked to changing body fat

Researchers have identified a biological marker that rises and falls as body fat changes, offering new insight into how weight gain and weight loss may influence metabolic health.

23 Jul 2026

AI platform uncovers promising target for chronic pain treatmen

Despite the widespread availability of analgesics, pain management remains one of the most significant and pervasive challenges in modern medicine, with more than 20% of the global population suffering from chronic pain, especially chronic neuropathic pain characterized by central sensitization.

22 Jul 2026

Handheld breathalyzer enables precise monitoring of fat metabolism

Researchers from ETH Zurich have developed a portable measuring device that detects the metabolic marker acetone in breath almost as accurately as a mass spectrometer.

22 Jul 2026

Unlocking the untapped 90%: Membrane protein purification as a three hours routine workflow

Automated, detergent-free purification preserves native membrane protein structure while supporting more reliable target validation workflows.

From Analytik Jena 21 Jul 2026

Study tests chronotype’s liver link and finds no significant association

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 medication-naïve adults with overweight or obesity. The exploratory findings cannot exclude smaller effects, particularly for fibrosis, and require confirmation in larger longitudinal studies.

21 Jul 2026

$Bone fractures often go unrecognized as early signs of osteoporosis$

Bone fractures often go unrecognized as early signs of osteoporosis

Many fractures are early-warning signs of osteoporosis. Yet in everyday clinical care they often go unrecognized and undocumented as warning signs, according to a new nationwide Austrian study by the Complexity Science Hub (CSH) and the Ludwig Boltzmann Institute for Osteology (LBI Osteology). Men are affected more often.

20 Jul 2026